Quick Links: Skip to main page content Skip to Search Skip to Topics Menu Skip to Common Links
  • Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Search Orphan Drug Designations and Approvals
  • Print
  • Share
  • E-mail
-
Generic Name: artemether/lumefantrine
Trade Name: Coartem
Date Designated: 08/31/2007
Orphan Designation: For the treatment of infections due to Plasmodium falciparum or mixed infections including P. falciparum.
Orphan Designation Status: Designated/Approved
Novartis Pharmaceuticals
Bldg 405/4051
One Health Plaza
East Hanover, New Jersey 07936
United States

The sponsor address listed is the last reported by the sponsor to OOPD.

Marketing approved:

1 Generic Name: artemether/lumefantrine
Trade Name: Coartem
Marketing Approval Date: 04/07/2009
Approved Labeled Indication: Treatment of malaria in patients of 5 kg bodyweight or above with acute, uncomplicated malaria due to Plasmodium falciparum or mixed infections including P. falciparum
Exclusivity End Date: 04/07/2016 
Exclusivity Protected Indication* :  
*Exclusivity Protected Indications are shown for approvals from 01/01/2013 to the present.
*Data for the Date Designation Withdrawn or Revoked field are shown for designations withdrawn or revoked after 08/12/2013.
-
-